A Longitudinal Observational Follow-up of the PRECEPT Study Cohort

The Parkinson Study Group55 个研究点分布在 2 个国家目标入组 530 人开始时间: 2006年8月最近更新: 2008年3月28日

适应症

试验速览

阶段: 不适用
发起方
入组人数: 530
试验地点: 55
主要终点: Unified Parkinson Disease Rating Scale (UPDRS) and β-CIT SPECT imaging of the dopamine transporter.

研究概览研究设计入排标准结局指标研究者研究点记录与标识符相似试验

研究概览

简要总结

The purpose of this study is to longitudinally follow consenting clinical trial participants who participated in PRECEPT (A Randomized, Double Blind, Placebo Controlled, Dose Finding Study to Assess the Efficacy and Safety of CEP 1347 in Patients With Early Parkinson's Disease). The study will assess the clinical and imaging outcomes relevant to the natural history of Parkinson's disease (PD), as well as determine early biomarkers of the disease.

研究设计

研究类型: Observational
观察模型: Cohort

入排标准

年龄范围: 30 Years 至 —（Adult, Older Adult）
性别: All
接受健康志愿者: 否

入选标准

•Participation in the PRECEPT study
•Willing and able to give informed consent

排除标准

•Patients will be excluded from participating in the the study if either of the criteria stated above is not met

结局指标

主要结局

Unified Parkinson Disease Rating Scale (UPDRS) and β-CIT SPECT imaging of the dopamine transporter.

时间窗: Annual, ongoing assessments

次要结局

University of Pennsylvania Smell Identification Test (UPSIT)(Annual, ongoing assessments)

研究者

发起方

The Parkinson Study Group

申办方类型

Network

研究点 (55)

Loading locations...

相似试验

终止

不适用

An Long-term Follow-up Trial of Kidney Tx Patients Treated With Imlifidase or PE After an AMRKidney Transplant Rejection

NCT04711850Hansa Biopharma AB18

已完成

不适用

A Follow up Study of Patients Treated With Imlifidase Prior to Kidney TransplantationKidney Transplant Failure and Rejection

NCT03611621Hansa Biopharma AB31

招募中

不适用

Long-term Follow-up of Study Participants Who Received an Allogeneic Chimeric Antigen Receptor T-Cell Product in an Imugene Ltd. Clinical StudyParticipants Who Received an Allogeneic Chimeric Antigen Receptor T-Cell Product (PBCAR) in a Precision BioSciences, Inc., Clinical Study

NCT05822427Imugene Limited75

终止

不适用

Observational Study Conducted on Patients Receiving the ESOP 2 Stem to Confirm Security and Performance of the DeviceHip DiseaseHip Fractures

NCT04193163FH ORTHO10

进行中（未招募）

不适用

Study Conducted on Patients Operated With a FHK ASYMETRIQUE to Confirm Security and Performance of the DeviceKnee Disease

NCT04221581FH ORTHO43